Causes of vision loss worldwide, 1990–2010: a systematic analysis
Data on causes of vision impairment and blindness are important for development of public health policies, but comprehensive analysis of change in prevalence over time is lacking. We did a systematic analysis of published and unpublished data on the causes of blindness (visual acuity in the better e...
Uložené v:
| Vydané v: | The Lancet global health Ročník 1; číslo 6; s. e339 - e349 |
|---|---|
| Hlavní autori: | , , , , , , , , , , , , |
| Médium: | Journal Article |
| Jazyk: | English |
| Vydavateľské údaje: |
England
Elsevier Ltd
01.12.2013
Elsevier |
| Predmet: | |
| ISSN: | 2214-109X, 2214-109X |
| On-line prístup: | Získať plný text |
| Tagy: |
Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
|
| Abstract | Data on causes of vision impairment and blindness are important for development of public health policies, but comprehensive analysis of change in prevalence over time is lacking.
We did a systematic analysis of published and unpublished data on the causes of blindness (visual acuity in the better eye less than 3/60) and moderate and severe vision impairment ([MSVI] visual acuity in the better eye less than 6/18 but at least 3/60) from 1980 to 2012. We estimated the proportions of overall vision impairment attributable to cataract, glaucoma, macular degeneration, diabetic retinopathy, trachoma, and uncorrected refractive error in 1990–2010 by age, geographical region, and year.
In 2010, 65% (95% uncertainty interval [UI] 61–68) of 32·4 million blind people and 76% (73–79) of 191 million people with MSVI worldwide had a preventable or treatable cause, compared with 68% (95% UI 65–70) of 31·8 million and 80% (78–83) of 172 million in 1990. Leading causes worldwide in 1990 and 2010 for blindness were cataract (39% and 33%, respectively), uncorrected refractive error (20% and 21%), and macular degeneration (5% and 7%), and for MSVI were uncorrected refractive error (51% and 53%), cataract (26% and 18%), and macular degeneration (2% and 3%). Causes of blindness varied substantially by region. Worldwide and in all regions more women than men were blind or had MSVI due to cataract and macular degeneration.
The differences and temporal changes we found in causes of blindness and MSVI have implications for planning and resource allocation in eye care.
Bill & Melinda Gates Foundation, Fight for Sight, Fred Hollows Foundation, and Brien Holden Vision Institute. |
|---|---|
| AbstractList | Background: Data on causes of vision impairment and blindness are important for development of public health policies, but comprehensive analysis of change in prevalence over time is lacking. Methods: We did a systematic analysis of published and unpublished data on the causes of blindness (visual acuity in the better eye less than 3/60) and moderate and severe vision impairment ([MSVI] visual acuity in the better eye less than 6/18 but at least 3/60) from 1980 to 2012. We estimated the proportions of overall vision impairment attributable to cataract, glaucoma, macular degeneration, diabetic retinopathy, trachoma, and uncorrected refractive error in 1990–2010 by age, geographical region, and year. Findings: In 2010, 65% (95% uncertainty interval [UI] 61–68) of 32·4 million blind people and 76% (73–79) of 191 million people with MSVI worldwide had a preventable or treatable cause, compared with 68% (95% UI 65–70) of 31·8 million and 80% (78–83) of 172 million in 1990. Leading causes worldwide in 1990 and 2010 for blindness were cataract (39% and 33%, respectively), uncorrected refractive error (20% and 21%), and macular degeneration (5% and 7%), and for MSVI were uncorrected refractive error (51% and 53%), cataract (26% and 18%), and macular degeneration (2% and 3%). Causes of blindness varied substantially by region. Worldwide and in all regions more women than men were blind or had MSVI due to cataract and macular degeneration. Interpretation: The differences and temporal changes we found in causes of blindness and MSVI have implications for planning and resource allocation in eye care. Funding: Bill & Melinda Gates Foundation, Fight for Sight, Fred Hollows Foundation, and Brien Holden Vision Institute. Data on causes of vision impairment and blindness are important for development of public health policies, but comprehensive analysis of change in prevalence over time is lacking. We did a systematic analysis of published and unpublished data on the causes of blindness (visual acuity in the better eye less than 3/60) and moderate and severe vision impairment ([MSVI] visual acuity in the better eye less than 6/18 but at least 3/60) from 1980 to 2012. We estimated the proportions of overall vision impairment attributable to cataract, glaucoma, macular degeneration, diabetic retinopathy, trachoma, and uncorrected refractive error in 1990–2010 by age, geographical region, and year. In 2010, 65% (95% uncertainty interval [UI] 61–68) of 32·4 million blind people and 76% (73–79) of 191 million people with MSVI worldwide had a preventable or treatable cause, compared with 68% (95% UI 65–70) of 31·8 million and 80% (78–83) of 172 million in 1990. Leading causes worldwide in 1990 and 2010 for blindness were cataract (39% and 33%, respectively), uncorrected refractive error (20% and 21%), and macular degeneration (5% and 7%), and for MSVI were uncorrected refractive error (51% and 53%), cataract (26% and 18%), and macular degeneration (2% and 3%). Causes of blindness varied substantially by region. Worldwide and in all regions more women than men were blind or had MSVI due to cataract and macular degeneration. The differences and temporal changes we found in causes of blindness and MSVI have implications for planning and resource allocation in eye care. Bill & Melinda Gates Foundation, Fight for Sight, Fred Hollows Foundation, and Brien Holden Vision Institute. Summary Background Data on causes of vision impairment and blindness are important for development of public health policies, but comprehensive analysis of change in prevalence over time is lacking. Methods We did a systematic analysis of published and unpublished data on the causes of blindness (visual acuity in the better eye less than 3/60) and moderate and severe vision impairment ([MSVI] visual acuity in the better eye less than 6/18 but at least 3/60) from 1980 to 2012. We estimated the proportions of overall vision impairment attributable to cataract, glaucoma, macular degeneration, diabetic retinopathy, trachoma, and uncorrected refractive error in 1990–2010 by age, geographical region, and year. Findings In 2010, 65% (95% uncertainty interval [UI] 61–68) of 32·4 million blind people and 76% (73–79) of 191 million people with MSVI worldwide had a preventable or treatable cause, compared with 68% (95% UI 65–70) of 31·8 million and 80% (78–83) of 172 million in 1990. Leading causes worldwide in 1990 and 2010 for blindness were cataract (39% and 33%, respectively), uncorrected refractive error (20% and 21%), and macular degeneration (5% and 7%), and for MSVI were uncorrected refractive error (51% and 53%), cataract (26% and 18%), and macular degeneration (2% and 3%). Causes of blindness varied substantially by region. Worldwide and in all regions more women than men were blind or had MSVI due to cataract and macular degeneration. Interpretation The differences and temporal changes we found in causes of blindness and MSVI have implications for planning and resource allocation in eye care. Funding Bill & Melinda Gates Foundation, Fight for Sight, Fred Hollows Foundation, and Brien Holden Vision Institute. Data on causes of vision impairment and blindness are important for development of public health policies, but comprehensive analysis of change in prevalence over time is lacking.BACKGROUNDData on causes of vision impairment and blindness are important for development of public health policies, but comprehensive analysis of change in prevalence over time is lacking.We did a systematic analysis of published and unpublished data on the causes of blindness (visual acuity in the better eye less than 3/60) and moderate and severe vision impairment ([MSVI] visual acuity in the better eye less than 6/18 but at least 3/60) from 1980 to 2012. We estimated the proportions of overall vision impairment attributable to cataract, glaucoma, macular degeneration, diabetic retinopathy, trachoma, and uncorrected refractive error in 1990-2010 by age, geographical region, and year.METHODSWe did a systematic analysis of published and unpublished data on the causes of blindness (visual acuity in the better eye less than 3/60) and moderate and severe vision impairment ([MSVI] visual acuity in the better eye less than 6/18 but at least 3/60) from 1980 to 2012. We estimated the proportions of overall vision impairment attributable to cataract, glaucoma, macular degeneration, diabetic retinopathy, trachoma, and uncorrected refractive error in 1990-2010 by age, geographical region, and year.In 2010, 65% (95% uncertainty interval [UI] 61-68) of 32·4 million blind people and 76% (73-79) of 191 million people with MSVI worldwide had a preventable or treatable cause, compared with 68% (95% UI 65-70) of 31·8 million and 80% (78-83) of 172 million in 1990. Leading causes worldwide in 1990 and 2010 for blindness were cataract (39% and 33%, respectively), uncorrected refractive error (20% and 21%), and macular degeneration (5% and 7%), and for MSVI were uncorrected refractive error (51% and 53%), cataract (26% and 18%), and macular degeneration (2% and 3%). Causes of blindness varied substantially by region. Worldwide and in all regions more women than men were blind or had MSVI due to cataract and macular degeneration.FINDINGSIn 2010, 65% (95% uncertainty interval [UI] 61-68) of 32·4 million blind people and 76% (73-79) of 191 million people with MSVI worldwide had a preventable or treatable cause, compared with 68% (95% UI 65-70) of 31·8 million and 80% (78-83) of 172 million in 1990. Leading causes worldwide in 1990 and 2010 for blindness were cataract (39% and 33%, respectively), uncorrected refractive error (20% and 21%), and macular degeneration (5% and 7%), and for MSVI were uncorrected refractive error (51% and 53%), cataract (26% and 18%), and macular degeneration (2% and 3%). Causes of blindness varied substantially by region. Worldwide and in all regions more women than men were blind or had MSVI due to cataract and macular degeneration.The differences and temporal changes we found in causes of blindness and MSVI have implications for planning and resource allocation in eye care.INTERPRETATIONThe differences and temporal changes we found in causes of blindness and MSVI have implications for planning and resource allocation in eye care.Bill & Melinda Gates Foundation, Fight for Sight, Fred Hollows Foundation, and Brien Holden Vision Institute.FUNDINGBill & Melinda Gates Foundation, Fight for Sight, Fred Hollows Foundation, and Brien Holden Vision Institute. |
| Author | Smith, Jennifer L Keeffe, Jill Bourne, Rupert R A Resnikoff, Serge Jonas, Jost B White, Richard A Pesudovs, Konrad Flaxman, Seth R Price, Holly Leasher, Janet Stevens, Gretchen A Naidoo, Kovin Taylor, Hugh R |
| Author_xml | – sequence: 1 givenname: Rupert R A surname: Bourne fullname: Bourne, Rupert R A email: rb@rupertbourne.co.uk organization: Vision and Eye Research Unit, Postgraduate Medical Institute, Anglia Ruskin University, Cambridge, UK – sequence: 2 givenname: Gretchen A surname: Stevens fullname: Stevens, Gretchen A organization: Department of Health Statistics and Information Systems, WHO, Geneva, Switzerland – sequence: 3 givenname: Richard A surname: White fullname: White, Richard A organization: Department of Genes and Environment, Division of Epidemiology, Norwegian Institute of Public Health, Oslo, Norway – sequence: 4 givenname: Jennifer L surname: Smith fullname: Smith, Jennifer L organization: Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK – sequence: 5 givenname: Seth R surname: Flaxman fullname: Flaxman, Seth R organization: School of Computer Science and Heinz College, Carnegie Mellon University, Pittsburgh, PA, USA – sequence: 6 givenname: Holly surname: Price fullname: Price, Holly organization: Vision and Eye Research Unit, Postgraduate Medical Institute, Anglia Ruskin University, Cambridge, UK – sequence: 7 givenname: Jost B surname: Jonas fullname: Jonas, Jost B organization: Department of Ophthalmology, Universitätsmedizin, Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany – sequence: 8 givenname: Jill surname: Keeffe fullname: Keeffe, Jill organization: LV Prasad Eye Institute, Hyderabad, India – sequence: 9 givenname: Janet surname: Leasher fullname: Leasher, Janet organization: College of Optometry, Nova Southeastern University, Fort-Lauderdale-Davie, FL, USA – sequence: 10 givenname: Kovin surname: Naidoo fullname: Naidoo, Kovin organization: African Vision Research Institute, University of Kwazulu-Natal, South Africa – sequence: 11 givenname: Konrad surname: Pesudovs fullname: Pesudovs, Konrad organization: NHMRC Centre for Clinical Eye Research, Flinders University, Adelaide, SA, Australia – sequence: 12 givenname: Serge surname: Resnikoff fullname: Resnikoff, Serge organization: International Health and Development, Geneva, Switzerland – sequence: 13 givenname: Hugh R surname: Taylor fullname: Taylor, Hugh R organization: Melbourne School of Public Health, University of Melbourne, Melbourne, VIC, Australia |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/25104599$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNkd9qFDEYxYO02Fr7CMpcVnA0f2cmioosVQsFL-zF3oVM8o1kzU5qMtOyd76Db-iTNLPTLlKQmpuEcM4vX855gvb60ANCzwh-RTCpXn-jlPCSYLk8IexFjQlh5fIROtxd7_11PkDHKa1wXlIyWteP0QEVBHMh5SFaLPSYIBWhK65ccqEvfEipuA7R22tn4WVBpMR_fv2mmOA3hS7SJg2w1oMzhe613ySXnqL9TvsEx7f7Ebr4dHqx-FKef_18tvh4XppKsKFsrCAdM0wwigEDE03TWSJFW7ddVRvDidG2JUJozqymVQW8yR-rrdW8kw07Qmcz1ga9UpfRrXXcqKCd2l6E-F3pmOfyoARvjRDQCEMrTo3QnSCiqSlnROrKsMw6mVmXMfwcIQ1q7ZIB73UPYUwqT0FZLTiWWfr8Vjq2a7C7h-8yzAIxC0zM0UXodhKC1VSX2talpi4UYWpbl1pm39t7PuOGHGzoh6idf9D9YXZDTvzKQVTJOOgNWBfBDDkT9yDh_T2C8a53RvsfsIG0CmPMBecsVKIKz5CJkSuZCBPg3b8B_zHADUEs1Jw |
| CitedBy_id | crossref_primary_10_1002_jcp_28189 crossref_primary_10_1016_j_ajo_2018_09_020 crossref_primary_10_1016_j_oftal_2023_05_006 crossref_primary_10_1016_j_foot_2023_102038 crossref_primary_10_1016_j_humimm_2025_111299 crossref_primary_10_1080_09286586_2018_1467466 crossref_primary_10_3389_fpubh_2024_1486168 crossref_primary_10_1007_s10792_017_0599_y crossref_primary_10_1080_09286586_2018_1467468 crossref_primary_10_3390_electronics12020262 crossref_primary_10_4103_ijo_IJO_256_22 crossref_primary_10_3389_fped_2023_1095495 crossref_primary_10_1039_c8pp00023a crossref_primary_10_1177_08971900221136897 crossref_primary_10_1371_journal_pone_0214875 crossref_primary_10_1007_s00417_022_05626_5 crossref_primary_10_2196_66052 crossref_primary_10_1016_j_cell_2019_01_004 crossref_primary_10_1097_IAE_0000000000001279 crossref_primary_10_1371_journal_pone_0204833 crossref_primary_10_3390_vaccines11091419 crossref_primary_10_1016_j_ophtha_2016_01_006 crossref_primary_10_1080_1354750X_2017_1279216 crossref_primary_10_1177_02646196241235284 crossref_primary_10_2337_dc20_0904 crossref_primary_10_1016_j_prostaglandins_2019_106407 crossref_primary_10_4103_IJO_IJO_2289_23 crossref_primary_10_1016_j_oftal_2018_10_020 crossref_primary_10_1155_2017_8597629 crossref_primary_10_1038_s41392_022_01257_8 crossref_primary_10_1038_s41598_022_11059_1 crossref_primary_10_1007_s10792_020_01307_6 crossref_primary_10_1136_bmjopen_2024_085853 crossref_primary_10_3389_fpubh_2023_1128008 crossref_primary_10_3390_jcm11010197 crossref_primary_10_1097_ICU_0000000000000364 crossref_primary_10_1364_JOSAA_559739 crossref_primary_10_1177_1120672120929958 crossref_primary_10_1016_j_joco_2017_05_006 crossref_primary_10_1155_2020_7319590 crossref_primary_10_7759_cureus_89755 crossref_primary_10_1097_j_jcrs_0000000000001170 crossref_primary_10_1016_j_diabres_2016_07_016 crossref_primary_10_1111_cxo_12646 crossref_primary_10_2337_dc15_2171 crossref_primary_10_3892_mmr_2018_8581 crossref_primary_10_1016_j_exer_2017_01_004 crossref_primary_10_1186_s13643_021_01704_7 crossref_primary_10_1002_cpt_1490 crossref_primary_10_1016_j_mimet_2017_04_010 crossref_primary_10_1177_08982643211012839 crossref_primary_10_1016_j_media_2019_101561 crossref_primary_10_1016_j_oftal_2021_01_007 crossref_primary_10_1080_09286586_2023_2188561 crossref_primary_10_1136_bmjopen_2021_054230 crossref_primary_10_3390_jcm10020336 crossref_primary_10_3390_vision3020025 crossref_primary_10_1371_journal_pone_0274705 crossref_primary_10_1016_j_ogla_2022_08_001 crossref_primary_10_1136_bjophthalmol_2017_311594 crossref_primary_10_1016_j_survophthal_2024_08_002 crossref_primary_10_1186_s12886_024_03445_2 crossref_primary_10_1136_bjophthalmol_2018_312980 crossref_primary_10_1007_s00347_016_0367_9 crossref_primary_10_1007_s13410_018_0617_2 crossref_primary_10_1177_02646196221144869 crossref_primary_10_1001_jamaophthalmol_2021_0640 crossref_primary_10_4103_tjo_tjo_10_21 crossref_primary_10_1186_s12886_021_02055_6 crossref_primary_10_1007_s10792_022_02383_6 crossref_primary_10_1080_09286586_2021_1961816 crossref_primary_10_1167_tvst_14_7_12 crossref_primary_10_2196_48616 crossref_primary_10_24190_ISSN2564_615X_2017_S1_23 crossref_primary_10_1111_aos_14644 crossref_primary_10_3892_br_2015_448 crossref_primary_10_1016_j_oftale_2021_01_007 crossref_primary_10_1080_13813455_2020_1776330 crossref_primary_10_1371_journal_pntd_0010943 crossref_primary_10_1007_s40200_018_0335_9 crossref_primary_10_1016_j_joco_2017_04_003 crossref_primary_10_1016_j_imu_2020_100377 crossref_primary_10_1097_IAE_0000000000002328 crossref_primary_10_1177_1120672118804079 crossref_primary_10_1186_s12955_022_01979_x crossref_primary_10_3390_app13042445 crossref_primary_10_14712_fb2024070040219 crossref_primary_10_1007_s11892_015_0649_7 crossref_primary_10_1186_s13584_019_0339_z crossref_primary_10_3390_ijerph182312440 crossref_primary_10_1177_2474126417702067 crossref_primary_10_1186_s12888_025_07125_3 crossref_primary_10_1016_j_exer_2024_109795 crossref_primary_10_1371_journal_pone_0237542 crossref_primary_10_4103_ijo_IJO_819_16 crossref_primary_10_3390_cells12131705 crossref_primary_10_3390_jcm12186062 crossref_primary_10_1097_IAE_0000000000001011 crossref_primary_10_1016_j_optom_2019_09_003 crossref_primary_10_22599_bioj_375 crossref_primary_10_1007_s10792_020_01316_5 crossref_primary_10_1038_s41598_025_93564_7 crossref_primary_10_3109_09286586_2015_1037847 crossref_primary_10_1167_iovs_18_25845 crossref_primary_10_1016_j_oftale_2023_05_012 crossref_primary_10_3390_medicina57121380 crossref_primary_10_4103_ijo_IJO_324_16 crossref_primary_10_1016_j_diabres_2020_108361 crossref_primary_10_3389_fpubh_2024_1393909 crossref_primary_10_1007_s00439_018_1945_5 crossref_primary_10_1016_j_ogla_2020_04_013 crossref_primary_10_1016_j_ajo_2019_03_020 crossref_primary_10_1109_ACCESS_2022_3177651 crossref_primary_10_1080_09286586_2016_1235715 crossref_primary_10_1097_IAE_0000000000002356 crossref_primary_10_3341_kjo_2017_0025 crossref_primary_10_12677_HJO_2021_102011 crossref_primary_10_1371_journal_pone_0175120 crossref_primary_10_1016_j_rmcr_2018_03_010 crossref_primary_10_1016_j_bspc_2024_106907 crossref_primary_10_3390_ijerph18189768 crossref_primary_10_1007_s00038_017_1000_7 crossref_primary_10_1167_iovs_65_11_29 crossref_primary_10_1007_s10278_020_00360_y crossref_primary_10_1111_aos_13773 crossref_primary_10_1016_j_ophtha_2015_06_052 crossref_primary_10_21122_2309_4923_2023_1_25_34 crossref_primary_10_1038_nature25013 crossref_primary_10_2196_56024 crossref_primary_10_1371_journal_pone_0175353 crossref_primary_10_3390_medicina56050252 crossref_primary_10_1146_annurev_vision_102016_061407 crossref_primary_10_1371_journal_pone_0211399 crossref_primary_10_3390_ijms25168876 crossref_primary_10_1097_MD_0000000000022659 crossref_primary_10_1186_s12889_023_15438_9 crossref_primary_10_3390_biom15091228 crossref_primary_10_1097_IJG_0000000000001014 crossref_primary_10_3390_jcm12062247 crossref_primary_10_1080_02713683_2019_1695844 crossref_primary_10_1093_rpd_ncad002 crossref_primary_10_2174_1874467215666211217122523 crossref_primary_10_1080_09286586_2016_1243718 crossref_primary_10_1111_ceo_13065 crossref_primary_10_3389_fphar_2019_00508 crossref_primary_10_1016_j_ajo_2018_07_013 crossref_primary_10_1016_j_oftale_2017_04_003 crossref_primary_10_3389_fmed_2021_618970 crossref_primary_10_3390_electronics11172740 crossref_primary_10_1007_s10792_025_03570_x crossref_primary_10_1016_j_ajo_2025_03_012 crossref_primary_10_1016_j_ophtha_2016_11_016 crossref_primary_10_12688_wellcomeopenres_13423_1 crossref_primary_10_1038_s41433_018_0017_3 crossref_primary_10_1039_c4pp90033b crossref_primary_10_12688_wellcomeopenres_13423_2 crossref_primary_10_1093_cid_ciaa1151 crossref_primary_10_1371_journal_pone_0196719 crossref_primary_10_1097_GME_0000000000000947 crossref_primary_10_3390_jcm10225432 crossref_primary_10_1016_j_artmed_2017_09_006 crossref_primary_10_1016_j_clae_2022_101772 crossref_primary_10_1136_bjophthalmol_2019_315217 crossref_primary_10_1186_s12886_018_0710_9 crossref_primary_10_4102_aveh_v79i1_518 crossref_primary_10_3233_JIFS_230128 crossref_primary_10_1038_s41598_019_46515_y crossref_primary_10_1001_jamaophthalmol_2018_2510 crossref_primary_10_1097_MD_0000000000017924 crossref_primary_10_1096_fj_202100350RR crossref_primary_10_1038_s41598_023_29916_y crossref_primary_10_1186_s12982_025_00481_1 crossref_primary_10_1007_s10384_020_00750_3 crossref_primary_10_1080_08820538_2016_1247180 crossref_primary_10_1088_2516_1091_ac812c crossref_primary_10_4103_IJO_IJO_3233_22 crossref_primary_10_1080_09286586_2018_1555262 crossref_primary_10_1016_j_oftale_2018_10_011 crossref_primary_10_1371_journal_pone_0305586 crossref_primary_10_1167_iovs_17_22731 crossref_primary_10_1371_journal_pone_0311392 crossref_primary_10_1016_j_curtheres_2020_100585 crossref_primary_10_1111_aos_17535 crossref_primary_10_1007_s10384_019_00686_3 crossref_primary_10_1080_09273948_2020_1811350 crossref_primary_10_1007_s10792_022_02424_0 crossref_primary_10_1049_ipr2_13211 crossref_primary_10_1016_j_intimp_2024_112334 crossref_primary_10_1016_j_yaoo_2017_03_003 crossref_primary_10_1007_s00417_018_4061_2 crossref_primary_10_1016_j_knosys_2020_106445 crossref_primary_10_1089_rej_2015_1718 crossref_primary_10_31083_FBL25584 crossref_primary_10_1016_j_ajo_2025_03_024 crossref_primary_10_1080_09286586_2018_1437188 crossref_primary_10_3390_biomedicines11051286 crossref_primary_10_1111_tmi_13039 crossref_primary_10_1155_2021_9385293 crossref_primary_10_1080_09286586_2023_2187068 crossref_primary_10_1136_jech_2016_207580 crossref_primary_10_1186_s12886_016_0389_8 crossref_primary_10_1186_s13690_023_01188_y crossref_primary_10_1371_journal_pone_0162229 crossref_primary_10_1001_jamaophthalmol_2018_6906 crossref_primary_10_1038_s41598_021_98488_6 crossref_primary_10_1097_ICU_0000000000001086 crossref_primary_10_3389_fmed_2025_1541304 crossref_primary_10_1002_hpm_2590 crossref_primary_10_3390_diagnostics15070912 crossref_primary_10_1136_bjophthalmol_2017_311746 crossref_primary_10_4103_IJO_IJO_2_23 crossref_primary_10_2147_OPTH_S275977 crossref_primary_10_1016_j_jcjo_2017_09_012 crossref_primary_10_3928_23258160_20250717_01 crossref_primary_10_1016_j_ibneur_2022_04_001 crossref_primary_10_1016_j_exer_2021_108629 crossref_primary_10_4274_tjo_galenos_2022_99602 crossref_primary_10_1186_s40662_015_0026_2 crossref_primary_10_1155_2019_2751475 crossref_primary_10_1111_bjd_15938 crossref_primary_10_1371_journal_pntd_0006289 crossref_primary_10_1371_journal_pone_0245329 crossref_primary_10_1080_22423982_2019_1709257 crossref_primary_10_1111_aos_13154 crossref_primary_10_4103_njo_njo_24_24 crossref_primary_10_1111_joim_12227 crossref_primary_10_1038_s41551_019_0446_8 crossref_primary_10_1016_j_jconrel_2024_01_007 crossref_primary_10_1186_s40662_022_00285_3 crossref_primary_10_1001_jama_2020_5576 crossref_primary_10_1038_s41598_024_74880_w crossref_primary_10_2147_OPTH_S283587 crossref_primary_10_3390_jcm12093210 crossref_primary_10_1186_s12885_024_12385_5 crossref_primary_10_2147_OPTH_S275968 crossref_primary_10_4103_jcor_jcor_78_25 crossref_primary_10_1038_s41433_017_0003_1 crossref_primary_10_1016_j_exer_2020_108332 crossref_primary_10_1016_j_lanepe_2025_101319 crossref_primary_10_1371_journal_pntd_0006023 crossref_primary_10_3390_app11094158 crossref_primary_10_1155_2018_1376020 crossref_primary_10_1097_MD_0000000000011377 crossref_primary_10_1007_s00592_023_02077_0 crossref_primary_10_1016_j_ajo_2020_03_035 crossref_primary_10_1016_j_bbamcr_2021_119024 crossref_primary_10_1016_j_ajo_2019_01_012 crossref_primary_10_1016_j_preteyeres_2018_04_006 crossref_primary_10_1371_journal_pone_0314467 crossref_primary_10_1167_iovs_17_23627 crossref_primary_10_1016_j_arr_2024_102358 crossref_primary_10_1080_09286586_2020_1730909 crossref_primary_10_1097_IJG_0000000000001427 crossref_primary_10_3389_fmed_2023_1115032 crossref_primary_10_1136_bjophthalmol_2019_315434 crossref_primary_10_1016_S0140_6736_17_31469_1 crossref_primary_10_1016_j_lanwpc_2025_101577 crossref_primary_10_1016_j_exer_2020_108329 crossref_primary_10_1016_j_rceng_2021_11_007 crossref_primary_10_3390_jpm12122057 crossref_primary_10_3390_ijerph16203854 crossref_primary_10_1139_cjpp_2019_0489 crossref_primary_10_1080_02713683_2023_2293457 crossref_primary_10_1177_17407745221136571 crossref_primary_10_1038_s41433_019_0401_7 crossref_primary_10_1371_journal_pone_0183364 crossref_primary_10_1111_ceo_13462 crossref_primary_10_1016_j_lfs_2019_116588 crossref_primary_10_1007_s40123_020_00325_y crossref_primary_10_1016_j_matchemphys_2021_125652 crossref_primary_10_1080_13816810_2019_1633549 crossref_primary_10_3389_fpubh_2022_981573 crossref_primary_10_1016_j_ophtha_2015_03_018 crossref_primary_10_1371_journal_pone_0172342 crossref_primary_10_3390_ijms22094721 crossref_primary_10_1097_IAE_0000000000001951 crossref_primary_10_1155_2018_4295184 crossref_primary_10_1093_bja_aew305 crossref_primary_10_1136_bjophthalmol_2016_309691 crossref_primary_10_1167_iovs_61_10_20 crossref_primary_10_2147_OPTH_S235751 crossref_primary_10_1016_j_jconrel_2024_01_063 crossref_primary_10_1016_j_ophtha_2015_03_017 crossref_primary_10_1111_opo_13117 crossref_primary_10_1111_opo_13118 crossref_primary_10_2147_JMDH_S473680 crossref_primary_10_4102_aveh_v75i1_327 crossref_primary_10_1007_s40123_021_00377_8 crossref_primary_10_1056_NEJMra1909637 crossref_primary_10_1016_j_bspc_2024_106346 crossref_primary_10_1186_s40537_023_00800_w crossref_primary_10_1186_s12960_016_0107_x crossref_primary_10_1039_c5pp00093a crossref_primary_10_1001_jamaophthalmol_2023_0723 crossref_primary_10_3390_nu10080959 crossref_primary_10_1186_s12889_025_23997_2 crossref_primary_10_1007_s11892_019_1134_5 crossref_primary_10_1167_iovs_64_1_14 crossref_primary_10_1177_0145482X1510900510 crossref_primary_10_1007_s40135_014_0059_z crossref_primary_10_1111_opo_13105 crossref_primary_10_1016_j_brainres_2014_11_020 crossref_primary_10_1177_11206721221083068 crossref_primary_10_1186_s12886_024_03309_9 crossref_primary_10_3389_fcimb_2017_00406 crossref_primary_10_1089_jmf_2025_k_0060 crossref_primary_10_1097_GME_0000000000000887 crossref_primary_10_1111_imm_13479 crossref_primary_10_3390_jcm13226849 crossref_primary_10_1080_09273948_2020_1746355 crossref_primary_10_1016_j_oftal_2016_02_006 crossref_primary_10_1167_iovs_66_12_10 crossref_primary_10_1109_ACCESS_2022_3178372 crossref_primary_10_1007_s00521_024_09820_w crossref_primary_10_1142_S0219519417400085 crossref_primary_10_1167_iovs_17_23536 crossref_primary_10_1371_journal_pone_0227240 crossref_primary_10_4103_ijo_IJO_2098_21 crossref_primary_10_1016_j_jcjo_2023_02_014 crossref_primary_10_1001_jamaophthalmol_2018_1719 crossref_primary_10_1007_s00441_023_03750_0 crossref_primary_10_1097_IJG_0000000000000643 crossref_primary_10_1590_0102_311xen138822 crossref_primary_10_3390_vaccines13010050 crossref_primary_10_1016_j_molimm_2024_05_005 crossref_primary_10_4108_eetpht_9_4376 crossref_primary_10_1016_j_foodchem_2019_125178 crossref_primary_10_1177_11206721231161101 crossref_primary_10_3109_09286586_2015_1104365 crossref_primary_10_4103_joco_joco_153_21 crossref_primary_10_1016_j_ajo_2024_12_022 crossref_primary_10_3390_ijms24098073 crossref_primary_10_1080_09286586_2017_1409358 crossref_primary_10_1080_09286586_2017_1409359 crossref_primary_10_1038_s41746_024_01207_4 crossref_primary_10_1111_aos_12908 crossref_primary_10_1089_jop_2020_0089 crossref_primary_10_1111_vop_12669 crossref_primary_10_1097_j_jcrs_0000000000000652 crossref_primary_10_1097_APO_0000000000000395 crossref_primary_10_3390_electronics11223810 crossref_primary_10_3233_NHA_160007 crossref_primary_10_1007_s11042_024_19353_y crossref_primary_10_1097_ICL_0000000000000677 crossref_primary_10_1016_j_joco_2018_12_001 crossref_primary_10_1109_ACCESS_2023_3330104 crossref_primary_10_1111_ceo_13036 crossref_primary_10_1093_inthealth_ihae071 crossref_primary_10_1038_s41598_018_29536_x crossref_primary_10_3390_separations11030083 crossref_primary_10_4102_aveh_v78i1_487 crossref_primary_10_2196_16146 crossref_primary_10_1111_opo_12224 crossref_primary_10_1007_s10495_025_02134_9 crossref_primary_10_1038_s41433_025_03884_1 crossref_primary_10_1080_15384101_2020_1777805 crossref_primary_10_7759_cureus_72920 crossref_primary_10_3389_fpubh_2024_1424031 crossref_primary_10_1007_s10792_025_03561_y crossref_primary_10_1155_2021_6612476 crossref_primary_10_3390_children9050632 crossref_primary_10_1016_j_ajo_2016_08_021 crossref_primary_10_2337_dc20_0413 crossref_primary_10_1186_s13098_018_0319_4 crossref_primary_10_1016_j_preteyeres_2019_100801 crossref_primary_10_1016_j_pharmthera_2017_01_003 crossref_primary_10_1016_j_bmcl_2019_06_027 crossref_primary_10_1111_opo_12692 crossref_primary_10_1016_j_pdpdt_2025_104499 crossref_primary_10_3390_antiox9080761 crossref_primary_10_1016_j_exer_2021_108693 crossref_primary_10_3390_ijms19010110 crossref_primary_10_1038_ejhg_2017_33 crossref_primary_10_1016_j_bspc_2025_108614 crossref_primary_10_1001_jamanetworkopen_2024_41166 crossref_primary_10_3390_jpm13091308 crossref_primary_10_1021_acs_jmedchem_5c00269 crossref_primary_10_1097_APO_0000000000000170 crossref_primary_10_11124_JBISRIR_2017_003419 crossref_primary_10_1016_j_jdiacomp_2019_05_006 crossref_primary_10_1016_j_pdpdt_2021_102355 crossref_primary_10_1097_IJG_0000000000000852 crossref_primary_10_1016_j_ajo_2022_08_011 crossref_primary_10_1016_j_ophtha_2018_01_023 crossref_primary_10_1371_journal_pone_0268800 crossref_primary_10_3390_ijerph17093240 crossref_primary_10_1371_journal_pone_0207690 crossref_primary_10_2147_OPTH_S248661 crossref_primary_10_3389_fphar_2019_00739 crossref_primary_10_1080_08923973_2023_2247545 crossref_primary_10_1167_iovs_62_12_22 crossref_primary_10_1016_j_ijpharm_2025_126009 crossref_primary_10_1186_s13063_023_07173_8 crossref_primary_10_1016_j_ajo_2018_12_008 crossref_primary_10_1016_j_compeleceng_2024_109880 crossref_primary_10_18502_jovr_v14i3_4790 crossref_primary_10_1016_j_ajo_2017_04_008 crossref_primary_10_3390_biom15030442 crossref_primary_10_1080_09286586_2018_1501077 crossref_primary_10_3390_ijerph13111142 crossref_primary_10_1038_nrdp_2015_14 crossref_primary_10_4239_wjd_v14_i10_1463 crossref_primary_10_1097_ICO_0000000000002791 crossref_primary_10_1155_2016_2156273 crossref_primary_10_1016_j_ajo_2019_05_006 crossref_primary_10_1167_iovs_62_2_35 crossref_primary_10_4103_tjo_TJO_D_23_00012 crossref_primary_10_4274_tjo_galenos_2021_29726 crossref_primary_10_1136_sextrans_2018_053938 crossref_primary_10_1080_09286586_2024_2434242 crossref_primary_10_1177_20552076221090042 crossref_primary_10_1016_j_diabres_2017_03_023 crossref_primary_10_1136_bjophthalmol_2021_319568 crossref_primary_10_1016_j_aej_2025_02_026 crossref_primary_10_1136_bjophthalmol_2014_306102 crossref_primary_10_17116_oftalma2024140021112 crossref_primary_10_3390_jcm10112296 crossref_primary_10_3390_pharmaceutics13010028 crossref_primary_10_1177_0300060520957447 crossref_primary_10_3390_info14010030 crossref_primary_10_1093_heapol_czx143 crossref_primary_10_12968_opti_2017_12_166228 crossref_primary_10_1080_09286586_2016_1259639 crossref_primary_10_1016_j_survophthal_2021_08_005 crossref_primary_10_1159_000513591 crossref_primary_10_1016_j_ijms_2017_10_008 crossref_primary_10_3389_fmed_2017_00251 crossref_primary_10_1097_ICU_0000000000000524 crossref_primary_10_1111_opo_13190 crossref_primary_10_3390_nu12103051 crossref_primary_10_1038_s41598_020_72618_y crossref_primary_10_1016_j_jep_2020_113715 crossref_primary_10_1109_ACCESS_2023_3272228 crossref_primary_10_1097_ICO_0000000000001488 crossref_primary_10_1080_02713683_2024_2407361 crossref_primary_10_4103_1319_4534_322621 crossref_primary_10_1080_09286586_2021_1953538 crossref_primary_10_1111_aos_12768 crossref_primary_10_3928_23258160_20180329_01 crossref_primary_10_4103_tjo_TJO_D_23_00032 crossref_primary_10_1371_journal_pone_0250468 crossref_primary_10_3389_fmed_2021_657566 crossref_primary_10_1177_1477153518792978 crossref_primary_10_1038_s41598_019_41917_4 crossref_primary_10_1097_MD_0000000000019468 crossref_primary_10_1016_j_ophtha_2021_07_032 crossref_primary_10_1007_s00125_020_05120_9 crossref_primary_10_1167_iovs_19_27325 crossref_primary_10_1111_bcp_15366 crossref_primary_10_1111_ceo_13410 crossref_primary_10_1111_jocn_14810 crossref_primary_10_1002_gps_5534 crossref_primary_10_1155_2021_8873283 crossref_primary_10_1007_s10654_015_0010_0 crossref_primary_10_1016_j_jcrs_2019_09_003 crossref_primary_10_1136_bmjopen_2014_005498 crossref_primary_10_1080_10645578_2020_1776562 crossref_primary_10_1038_eye_2016_261 crossref_primary_10_1136_bmjopen_2020_044805 crossref_primary_10_7759_cureus_33976 crossref_primary_10_1088_1748_605X_ad1c9e crossref_primary_10_1111_ceo_12331 crossref_primary_10_1113_EP090090 crossref_primary_10_1186_s40942_020_00234_z crossref_primary_10_1038_s41433_024_03101_5 crossref_primary_10_1080_09286586_2020_1716379 crossref_primary_10_2196_52410 crossref_primary_10_1007_s13167_023_00319_3 crossref_primary_10_1016_j_ophtha_2018_04_013 crossref_primary_10_1016_j_ophtha_2018_02_005 crossref_primary_10_1136_bmjopen_2021_053805 crossref_primary_10_1016_j_dsx_2018_12_012 crossref_primary_10_1136_bjophthalmol_2021_319769 crossref_primary_10_1016_j_oftale_2016_05_004 crossref_primary_10_1136_jmedgenet_2022_108425 crossref_primary_10_3390_antiox12040853 crossref_primary_10_1111_bph_15629 crossref_primary_10_1097_APO_0000000000000304 crossref_primary_10_1186_s13584_025_00667_7 crossref_primary_10_62517_jbdc_202401322 crossref_primary_10_22608_APO_2017251 crossref_primary_10_1111_ceo_12581 crossref_primary_10_1371_journal_pone_0111320 crossref_primary_10_1016_j_actbio_2020_08_044 crossref_primary_10_1167_iovs_62_4_25 crossref_primary_10_17925_EOR_2018_12_1_39 crossref_primary_10_1007_s11042_024_19048_4 crossref_primary_10_1097_IAE_0000000000003278 crossref_primary_10_1080_09286586_2021_1941127 crossref_primary_10_1136_bjophthalmol_2015_307527 crossref_primary_10_1038_s41598_019_41009_3 crossref_primary_10_1186_s12886_023_03009_w crossref_primary_10_1007_s00125_018_4682_3 crossref_primary_10_1371_journal_pntd_0005863 crossref_primary_10_1007_s00417_022_05653_2 crossref_primary_10_4103_JOCO_JOCO_50_20 crossref_primary_10_1289_EHP9873 crossref_primary_10_1080_09286586_2023_2213320 crossref_primary_10_1080_09286586_2016_1238945 crossref_primary_10_1177_1932296816629491 crossref_primary_10_3928_23258160_20180831_07 crossref_primary_10_1136_bjo_2024_326662 crossref_primary_10_1007_s00417_020_04860_z crossref_primary_10_1007_s12013_015_0565_0 crossref_primary_10_3390_ijerph20010875 crossref_primary_10_1016_j_patrec_2020_04_009 crossref_primary_10_1007_s00592_019_01466_8 crossref_primary_10_1177_20503121221095324 crossref_primary_10_4103_IJO_IJO_2660_22 crossref_primary_10_1016_j_biomaterials_2018_12_015 crossref_primary_10_3389_fphys_2018_01233 crossref_primary_10_1111_opo_12283 crossref_primary_10_3389_fmed_2022_914504 crossref_primary_10_3390_ijerph17228561 crossref_primary_10_1007_s12603_020_1319_2 crossref_primary_10_1186_s12913_017_2787_x crossref_primary_10_1097_ICU_0000000000000340 crossref_primary_10_3389_fnagi_2021_643685 crossref_primary_10_29333_ejgm_9347 crossref_primary_10_1186_s12883_022_02807_x crossref_primary_10_1038_s41598_023_42108_y crossref_primary_10_1007_s13300_021_01188_7 crossref_primary_10_1038_s41598_022_17753_4 crossref_primary_10_1038_s42003_022_04323_7 crossref_primary_10_1080_09286586_2016_1247877 crossref_primary_10_1093_inthealth_ihu049 crossref_primary_10_1080_09286586_2016_1247875 crossref_primary_10_1080_09286586_2016_1247876 crossref_primary_10_3390_ijerph22040485 crossref_primary_10_1017_S1368980021001324 crossref_primary_10_1039_D0FO03321A crossref_primary_10_1038_s41746_019_0154_5 crossref_primary_10_1111_aos_13477 crossref_primary_10_1038_s41598_023_37619_7 crossref_primary_10_1016_j_ophtha_2020_11_025 crossref_primary_10_1016_S0140_6736_15_00346_3 crossref_primary_10_1038_eye_2014_239 crossref_primary_10_1136_bjophthalmol_2017_311266 crossref_primary_10_1038_eye_2015_271 crossref_primary_10_1016_j_aopr_2024_01_001 crossref_primary_10_3390_ijtm2010001 crossref_primary_10_1186_s12874_021_01243_8 crossref_primary_10_1186_s12886_024_03762_6 crossref_primary_10_1016_j_exer_2018_11_022 crossref_primary_10_1111_aos_14562 crossref_primary_10_1177_0300985815625169 crossref_primary_10_1186_s40942_024_00543_7 crossref_primary_10_1039_C8FO01408F crossref_primary_10_1186_s12889_020_09255_7 crossref_primary_10_1136_bjophthalmol_2017_311258 crossref_primary_10_3928_1081597X_20170310_01 crossref_primary_10_3892_mmr_2019_10151 crossref_primary_10_1186_s12886_020_01673_w crossref_primary_10_1111_gtc_13150 crossref_primary_10_1186_s12967_022_03323_9 crossref_primary_10_1111_aos_14791 crossref_primary_10_3390_ijms22084020 crossref_primary_10_2147_DMSO_S300373 crossref_primary_10_3390_ijms23031362 crossref_primary_10_2147_DDDT_S427416 crossref_primary_10_1111_aos_15641 crossref_primary_10_1080_08164622_2022_2048172 crossref_primary_10_3390_ijerph182312375 crossref_primary_10_1371_journal_pone_0225627 crossref_primary_10_3389_fendo_2025_1462210 crossref_primary_10_1016_j_dsp_2023_104308 crossref_primary_10_1097_MD9_0000000000000364 crossref_primary_10_1111_ceo_12954 crossref_primary_10_1016_j_compbiomed_2022_105602 crossref_primary_10_3390_diagnostics13101706 crossref_primary_10_1016_j_ajpath_2023_05_004 crossref_primary_10_3389_fimmu_2019_02958 crossref_primary_10_1080_09286586_2019_1678654 crossref_primary_10_29254_2077_4214_2022_4_167_210_222 crossref_primary_10_1016_j_clinthera_2021_08_011 crossref_primary_10_1016_j_xops_2025_100824 crossref_primary_10_1080_09286586_2022_2127784 crossref_primary_10_1080_09286586_2025_2473714 crossref_primary_10_1016_j_addr_2018_01_007 crossref_primary_10_1080_08164622_2022_2030650 crossref_primary_10_2147_OPTH_S231801 crossref_primary_10_1177_11206721241255156 crossref_primary_10_1007_s40123_021_00380_z crossref_primary_10_1016_j_exer_2022_109094 crossref_primary_10_1080_09286586_2021_1910314 crossref_primary_10_1111_ceo_12717 crossref_primary_10_1016_j_media_2019_05_009 crossref_primary_10_3389_fmed_2021_778117 crossref_primary_10_1097_MD_0000000000026938 crossref_primary_10_1136_bmj_l5887 crossref_primary_10_1186_s12886_021_02172_2 crossref_primary_10_1109_ACCESS_2021_3125791 crossref_primary_10_1088_1741_2552_abf523 crossref_primary_10_1371_journal_pntd_0005230 crossref_primary_10_1016_j_clae_2019_11_012 crossref_primary_10_1097_ICO_0000000000002237 crossref_primary_10_1136_bmjopen_2019_032654 crossref_primary_10_1007_s10278_024_01243_2 crossref_primary_10_1016_j_ogla_2021_06_001 crossref_primary_10_3390_nu11051186 crossref_primary_10_2337_dc20_1085 crossref_primary_10_1016_j_hermed_2024_100943 crossref_primary_10_3390_vision5020016 crossref_primary_10_1177_02646196221085848 crossref_primary_10_1186_s12886_023_02969_3 crossref_primary_10_1088_1741_2552_ab3913 crossref_primary_10_1097_IJG_0000000000001125 crossref_primary_10_7759_cureus_42730 crossref_primary_10_1080_09286586_2019_1708120 crossref_primary_10_3390_diagnostics14151633 crossref_primary_10_1007_s00417_019_04484_y crossref_primary_10_1186_s12886_021_01933_3 crossref_primary_10_1096_fj_202501265RR crossref_primary_10_1371_journal_pone_0170804 crossref_primary_10_1007_s40200_022_01094_0 crossref_primary_10_1167_iovs_18_25958 crossref_primary_10_64095_ajst_v2i1_55 crossref_primary_10_1038_s41598_022_23607_w crossref_primary_10_1136_bmjopen_2022_069702 crossref_primary_10_3389_fphys_2022_788034 crossref_primary_10_1007_s00204_018_2344_3 crossref_primary_10_1016_S2213_8587_17_30181_X crossref_primary_10_9778_cmajo_20200104 crossref_primary_10_1016_j_preteyeres_2022_101097 crossref_primary_10_1371_journal_pone_0202347 crossref_primary_10_3390_s20082435 crossref_primary_10_1080_07420528_2025_2509631 crossref_primary_10_1124_jpet_118_248427 crossref_primary_10_1016_j_rce_2021_11_007 crossref_primary_10_1167_iovs_19_27921 crossref_primary_10_1371_journal_pone_0290240 crossref_primary_10_5937_afmnai40_40667 crossref_primary_10_1016_j_ajpath_2020_05_008 crossref_primary_10_1080_08820538_2021_1887901 crossref_primary_10_1155_2020_9204620 crossref_primary_10_1016_j_cbi_2020_109249 crossref_primary_10_1186_s12886_024_03337_5 crossref_primary_10_1001_jamaophthalmol_2018_4229 crossref_primary_10_1177_11206721221140948 crossref_primary_10_1038_s41598_021_01557_z crossref_primary_10_1136_bmjopen_2018_021496 crossref_primary_10_1007_s11892_021_01411_6 crossref_primary_10_1109_ACCESS_2024_3506714 crossref_primary_10_1186_s13071_018_2682_2 crossref_primary_10_1111_cge_13722 crossref_primary_10_1080_15548627_2021_1872188 crossref_primary_10_1002_jcb_25899 crossref_primary_10_3390_ijms20194845 crossref_primary_10_1016_j_jpeds_2020_04_059 crossref_primary_10_1089_biores_2017_0036 crossref_primary_10_1097_ICL_0000000000001188 crossref_primary_10_1111_aos_14980 crossref_primary_10_1371_journal_pone_0326176 crossref_primary_10_1080_14728214_2020_1810664 crossref_primary_10_3389_fmed_2025_1544765 crossref_primary_10_4102_aveh_v77i1_393 crossref_primary_10_1093_bmb_ldaa012 crossref_primary_10_2147_DMSO_S304904 crossref_primary_10_1016_j_jtemb_2024_127573 crossref_primary_10_7759_cureus_71063 crossref_primary_10_1007_s13410_025_01527_5 crossref_primary_10_1136_bjophthalmol_2020_317890 crossref_primary_10_1097_IIO_0000000000000287 crossref_primary_10_1038_s41598_021_89225_0 crossref_primary_10_1080_00981389_2019_1614711 crossref_primary_10_1016_j_diabres_2018_03_037 crossref_primary_10_1016_j_ejmech_2020_112523 crossref_primary_10_1038_s41598_023_50597_0 crossref_primary_10_1038_s41598_017_13283_6 crossref_primary_10_1177_0264619620915263 crossref_primary_10_3390_cells13221907 crossref_primary_10_3390_ijerph182312750 crossref_primary_10_1186_s13063_020_04595_6 crossref_primary_10_3389_fendo_2022_987401 crossref_primary_10_1186_s12879_019_3992_5 crossref_primary_10_2147_IJGM_S326046 crossref_primary_10_1088_1741_2552_ab5299 crossref_primary_10_4103_ijo_IJO_1503_21 crossref_primary_10_1136_bjophthalmol_2018_311946 crossref_primary_10_1097_IAE_0000000000001312 crossref_primary_10_1097_IAE_0000000000001554 crossref_primary_10_1007_s10792_017_0639_7 crossref_primary_10_1155_2022_4701796 crossref_primary_10_1371_journal_pntd_0005277 crossref_primary_10_2471_BLT_18_212613 crossref_primary_10_1016_j_bmcl_2018_12_043 crossref_primary_10_1097_ICL_0000000000000736 crossref_primary_10_1097_ICL_0000000000000978 crossref_primary_10_1371_journal_pntd_0006110 crossref_primary_10_1136_bjo_2023_323878 crossref_primary_10_1111_jcmm_14438 crossref_primary_10_3389_fphar_2017_00333 crossref_primary_10_1016_j_jinf_2020_01_015 crossref_primary_10_1186_1471_2415_14_43 crossref_primary_10_1109_TMI_2019_2927226 crossref_primary_10_1177_03000605241304586 crossref_primary_10_3390_ijms242417385 crossref_primary_10_1111_aos_14391 crossref_primary_10_3389_fmed_2022_860574 crossref_primary_10_1007_s10654_018_00478_y crossref_primary_10_3390_app10062021 crossref_primary_10_1016_S0140_6736_18_31550_2 crossref_primary_10_3109_02713683_2016_1143013 crossref_primary_10_3390_photonics12080815 crossref_primary_10_1002_advs_202402368 crossref_primary_10_1186_s12902_017_0170_x crossref_primary_10_3928_1081597X_20180326_01 crossref_primary_10_1016_j_compmedimag_2025_102494 crossref_primary_10_1186_s12967_022_03425_4 crossref_primary_10_2147_OPTH_S473788 crossref_primary_10_1038_s42003_020_01421_2 crossref_primary_10_1016_j_jfma_2020_12_026 crossref_primary_10_4103_ijo_IJO_831_21 crossref_primary_10_3389_fcimb_2018_00415 crossref_primary_10_1167_iovs_18_26182 crossref_primary_10_1097_IAE_0000000000001335 crossref_primary_10_1016_j_ophtha_2017_05_002 crossref_primary_10_1007_s40123_024_00917_y crossref_primary_10_7759_cureus_48256 crossref_primary_10_1007_s10384_024_01134_7 crossref_primary_10_1088_2632_2153_ad0798 crossref_primary_10_1001_jamaophthalmol_2018_2658 crossref_primary_10_1038_s41433_024_03078_1 crossref_primary_10_1016_j_ophtha_2019_08_002 crossref_primary_10_1007_s00417_021_05365_z crossref_primary_10_1097_CM9_0000000000000319 crossref_primary_10_3928_23258160_20210926_01 crossref_primary_10_1007_s12603_015_0648_z crossref_primary_10_1111_cxo_12377 crossref_primary_10_1136_bjophthalmol_2015_308156 crossref_primary_10_1177_11206721221143166 crossref_primary_10_1042_BSR20212209 crossref_primary_10_1186_s12906_023_04204_4 crossref_primary_10_1038_s41598_025_16791_y crossref_primary_10_1159_000510572 crossref_primary_10_1167_iovs_64_7_17 crossref_primary_10_1007_s00417_015_3026_y crossref_primary_10_1007_s00592_020_01602_9 crossref_primary_10_3390_s21072450 crossref_primary_10_3390_life11111137 crossref_primary_10_3389_fnins_2025_1560344 crossref_primary_10_1080_09286586_2025_2457629 crossref_primary_10_3390_v13081610 crossref_primary_10_1016_j_oftale_2019_05_004 crossref_primary_10_2471_BLT_15_156844 crossref_primary_10_1016_j_aprim_2018_10_001 crossref_primary_10_1089_jop_2018_0141 crossref_primary_10_1186_s12886_023_03177_9 crossref_primary_10_1111_opo_12746 crossref_primary_10_1186_s13071_018_2686_y crossref_primary_10_1016_j_eswa_2021_115211 crossref_primary_10_3892_etm_2019_8250 crossref_primary_10_3390_nu11030649 crossref_primary_10_1007_s10965_016_1137_8 crossref_primary_10_1016_j_ophtha_2019_09_010 crossref_primary_10_1007_s11357_019_00138_3 crossref_primary_10_3390_photonics10090999 crossref_primary_10_1016_j_ajo_2017_06_015 crossref_primary_10_1136_bjophthalmol_2013_304013 crossref_primary_10_1186_s12916_015_0343_2 crossref_primary_10_3390_s21113704 crossref_primary_10_1002_term_2499 crossref_primary_10_3390_data3030025 crossref_primary_10_3390_en14133827 crossref_primary_10_1016_j_pdpdt_2024_104218 crossref_primary_10_2196_12539 crossref_primary_10_21300_19_3_2018_605 crossref_primary_10_1111_opo_12976 crossref_primary_10_1016_j_ijheh_2023_114171 crossref_primary_10_1007_s10928_021_09774_9 crossref_primary_10_1038_s41433_021_01870_x crossref_primary_10_1080_09286586_2017_1418897 crossref_primary_10_1371_journal_pone_0313019 crossref_primary_10_1186_s12886_020_01479_w crossref_primary_10_2147_OPTH_S241628 crossref_primary_10_1111_aos_14343 crossref_primary_10_1186_s12889_021_12106_8 crossref_primary_10_1371_journal_pone_0166915 crossref_primary_10_5604_01_3001_0014_6589 crossref_primary_10_1080_02713683_2022_2055084 crossref_primary_10_2147_OPTH_S264984 crossref_primary_10_1016_j_ajo_2017_07_024 crossref_primary_10_1016_j_ejps_2018_04_043 crossref_primary_10_1073_pnas_1615970114 crossref_primary_10_1007_s00592_017_0984_z crossref_primary_10_1016_j_media_2020_101695 crossref_primary_10_1136_bmjopen_2015_010381 crossref_primary_10_1007_s40005_023_00653_8 crossref_primary_10_1167_iovs_61_2_22 crossref_primary_10_1016_j_jcjo_2020_12_010 crossref_primary_10_1016_j_chbah_2023_100029 crossref_primary_10_1016_j_jbi_2022_104233 crossref_primary_10_1177_11206721221090700 crossref_primary_10_1016_j_ebiom_2015_11_006 crossref_primary_10_1016_S0140_6736_19_32481_X crossref_primary_10_1038_s41746_025_01750_8 crossref_primary_10_4103_joco_joco_290_23 crossref_primary_10_1136_bmjopen_2019_033139 crossref_primary_10_3389_fopht_2025_1641194 crossref_primary_10_1016_j_cmpbup_2025_100182 crossref_primary_10_1007_s12672_025_02864_x crossref_primary_10_1177_02646196221099147 crossref_primary_10_1155_2021_5013529 crossref_primary_10_1016_j_preteyeres_2016_09_002 crossref_primary_10_1007_s12325_016_0333_6 crossref_primary_10_1080_08820538_2017_1353817 crossref_primary_10_1371_journal_pone_0253210 crossref_primary_10_1007_s11892_015_0652_z crossref_primary_10_1016_j_media_2021_101971 crossref_primary_10_3389_fnagi_2019_00363 crossref_primary_10_1007_s00347_017_0616_6 crossref_primary_10_1186_s12886_020_01394_0 crossref_primary_10_1371_journal_pone_0160240 crossref_primary_10_1016_j_oftal_2017_04_003 crossref_primary_10_1080_08820538_2017_1417453 crossref_primary_10_3389_fmolb_2022_873777 crossref_primary_10_1097_APO_0000000000000224 crossref_primary_10_1371_journal_pntd_0005099 crossref_primary_10_1007_s10792_016_0348_7 crossref_primary_10_1111_ceo_12273 crossref_primary_10_1136_bjophthalmol_2018_312292 crossref_primary_10_1186_s12911_022_01996_2 crossref_primary_10_2147_OPTH_S391282 crossref_primary_10_1111_jgs_15266 crossref_primary_10_1016_j_survophthal_2023_02_008 crossref_primary_10_3390_biom10040645 crossref_primary_10_1080_08820538_2019_1620794 crossref_primary_10_1038_s41598_024_54325_0 crossref_primary_10_1038_srep16304 crossref_primary_10_1088_2057_1976_ada8ad crossref_primary_10_4239_wjd_v9_i7_99 crossref_primary_10_1167_iovs_18_26108 crossref_primary_10_1038_s41598_022_07924_8 crossref_primary_10_1097_APO_0000000000000496 crossref_primary_10_1136_bmjopen_2021_051761 crossref_primary_10_4103_IJO_IJO_2570_22 crossref_primary_10_3390_nu9101120 crossref_primary_10_1016_j_preteyeres_2017_12_002 crossref_primary_10_4102_aveh_v77i1_402 crossref_primary_10_4102_aveh_v77i1_401 crossref_primary_10_4239_wjd_v12_i7_939 crossref_primary_10_1097_APO_0000000000000257 crossref_primary_10_1016_j_clae_2025_102508 crossref_primary_10_1111_opo_13213 crossref_primary_10_1007_s00417_021_05285_y crossref_primary_10_1109_JBHI_2020_3046771 crossref_primary_10_1177_1060028017733272 crossref_primary_10_3389_fmed_2022_1069649 crossref_primary_10_4103_0301_4738_178152 crossref_primary_10_1186_s12886_021_02124_w crossref_primary_10_1093_inthealth_ihaf067 crossref_primary_10_1016_j_ajo_2018_05_017 crossref_primary_10_5194_essd_12_2787_2020 crossref_primary_10_1080_09286586_2021_1986549 crossref_primary_10_1080_17441692_2016_1241816 crossref_primary_10_4103_ijo_IJO_1266_22 crossref_primary_10_1136_bjophthalmol_2018_312068 crossref_primary_10_1016_j_actbio_2017_09_023 crossref_primary_10_1371_journal_pgen_1007244 crossref_primary_10_1016_j_pec_2020_10_036 crossref_primary_10_2337_dc18_1809 crossref_primary_10_1080_09286586_2021_2015784 crossref_primary_10_1016_j_jconrel_2017_09_036 crossref_primary_10_3390_diagnostics13122084 crossref_primary_10_1016_j_bbr_2022_114130 crossref_primary_10_1097_IJG_0000000000001616 crossref_primary_10_2147_OPTH_S258783 crossref_primary_10_3389_fnsys_2017_00082 crossref_primary_10_1007_s11277_020_07216_2 crossref_primary_10_1186_s12886_024_03790_2 crossref_primary_10_3390_nursrep15010023 crossref_primary_10_2105_AJPH_2016_303631 crossref_primary_10_1016_j_drugalcdep_2021_109149 crossref_primary_10_1016_j_bspc_2020_102167 crossref_primary_10_3390_ph18040523 crossref_primary_10_1111_cxo_13040 crossref_primary_10_1016_j_diabres_2018_07_004 crossref_primary_10_1097_APO_0000000000000275 crossref_primary_10_1136_bmjopen_2017_018478 crossref_primary_10_1007_s00417_022_05839_8 crossref_primary_10_1038_s41598_024_51749_6 crossref_primary_10_1016_j_techfore_2018_10_012 crossref_primary_10_3389_fcell_2021_645501 crossref_primary_10_3389_fpubh_2022_966006 crossref_primary_10_5888_pcd20_220210 crossref_primary_10_1038_s41433_022_01937_3 crossref_primary_10_1016_j_exer_2015_09_007 crossref_primary_10_3390_nu14061252 crossref_primary_10_1097_IJG_0000000000000941 crossref_primary_10_1159_000531723 crossref_primary_10_4103_IJO_IJO_3050_22 crossref_primary_10_1155_crop_6657874 crossref_primary_10_3390_children8111054 crossref_primary_10_1186_s12886_020_01392_2 crossref_primary_10_1016_j_ophtha_2019_03_033 crossref_primary_10_3389_fpubh_2023_1194320 crossref_primary_10_1016_j_ajog_2016_11_1043 crossref_primary_10_1016_j_ajo_2017_10_010 crossref_primary_10_1080_02713683_2019_1576907 crossref_primary_10_1038_s41598_022_08297_8 crossref_primary_10_1088_1361_6560_ad1273 crossref_primary_10_4103_jpbs_jpbs_199_21 crossref_primary_10_1007_s10384_016_0468_7 crossref_primary_10_1016_j_heliyon_2024_e33813 crossref_primary_10_1016_j_oret_2019_02_001 crossref_primary_10_3928_23258160_20240805_03 crossref_primary_10_1136_bjophthalmol_2016_309514 crossref_primary_10_1186_s12955_025_02411_w crossref_primary_10_1007_s40266_023_01068_8 crossref_primary_10_1080_09286586_2017_1367409 crossref_primary_10_3390_jcm11102761 crossref_primary_10_1007_s10522_023_10019_0 crossref_primary_10_1097_MD_0000000000042911 crossref_primary_10_1097_IJG_0000000000000976 crossref_primary_10_1186_s12886_018_0699_0 crossref_primary_10_1002_nano_202100137 crossref_primary_10_4102_aveh_v83i1_940 crossref_primary_10_1371_journal_pone_0254517 crossref_primary_10_22608_APO_2017511 crossref_primary_10_1007_s40200_022_01033_z crossref_primary_10_1177_1120672119830578 crossref_primary_10_1136_bmjopen_2017_016280 crossref_primary_10_1111_cxo_13030 crossref_primary_10_1016_j_ijnurstu_2019_103417 crossref_primary_10_1016_j_exger_2018_02_029 crossref_primary_10_1371_journal_pone_0189622 crossref_primary_10_3390_jpm13020289 crossref_primary_10_1038_s41598_025_96582_7 crossref_primary_10_1371_journal_pone_0229108 crossref_primary_10_1007_s12612_015_0466_2 crossref_primary_10_1111_aos_13513 crossref_primary_10_1177_11206721231184544 crossref_primary_10_1016_j_preteyeres_2020_100900 crossref_primary_10_1136_bmjopen_2024_090916 crossref_primary_10_1371_journal_pone_0215329 crossref_primary_10_22608_APO_2018438 crossref_primary_10_1002_cbin_11615 crossref_primary_10_1038_s41598_024_75486_y crossref_primary_10_3389_fcell_2023_1267232 crossref_primary_10_1136_bmjophth_2018_000236 crossref_primary_10_4103_ijo_IJO_837_21 crossref_primary_10_1016_j_nano_2018_11_002 crossref_primary_10_1016_j_tice_2024_102687 crossref_primary_10_1007_s00347_022_01737_w crossref_primary_10_1016_j_jdiacomp_2017_10_004 crossref_primary_10_1007_s00500_025_10773_y crossref_primary_10_2217_pgs_15_173 crossref_primary_10_3390_s23010362 crossref_primary_10_1113_JP282454 crossref_primary_10_1016_j_ajo_2024_05_019 crossref_primary_10_1016_j_yrtph_2019_104509 crossref_primary_10_1039_D2FO02788G crossref_primary_10_1177_24741264231200735 crossref_primary_10_1038_s41598_017_15056_7 crossref_primary_10_1038_s41598_022_25599_z crossref_primary_10_1093_trstmh_trz042 crossref_primary_10_1136_bjophthalmol_2020_318646 crossref_primary_10_1016_j_optom_2020_08_003 crossref_primary_10_1111_vop_12517 crossref_primary_10_1007_s43450_025_00638_8 crossref_primary_10_21122_2309_4923_2022_3_12_21 crossref_primary_10_1371_journal_pone_0189881 crossref_primary_10_1007_s00281_019_00750_7 crossref_primary_10_1016_j_ophtha_2017_01_020 crossref_primary_10_18502_jovr_v16i3_9439 crossref_primary_10_1007_s00062_018_0728_7 crossref_primary_10_1016_j_ijheh_2016_07_012 crossref_primary_10_3390_cells10092394 crossref_primary_10_1038_s41433_021_01417_0 crossref_primary_10_1136_bjophthalmol_2018_313308 crossref_primary_10_1016_j_ophtha_2020_08_031 crossref_primary_10_1177_11206721241248478 crossref_primary_10_7759_cureus_54129 crossref_primary_10_1080_09286586_2017_1376338 crossref_primary_10_4103_ijo_IJO_15_22 crossref_primary_10_1038_srep28500 crossref_primary_10_4102_aveh_v83i1_901 crossref_primary_10_1109_JBHI_2020_2983549 crossref_primary_10_1097_APO_0000000000000406 crossref_primary_10_1136_bjophthalmol_2018_313798 crossref_primary_10_3390_app10248865 crossref_primary_10_1186_s13104_018_3660_7 crossref_primary_10_1007_s12325_017_0541_8 crossref_primary_10_3390_app14177816 crossref_primary_10_1007_s00417_021_05217_w crossref_primary_10_1038_s41433_023_02439_6 crossref_primary_10_1186_s12889_022_14377_1 crossref_primary_10_3390_ijerph15030435 crossref_primary_10_1016_j_biocel_2017_11_013 crossref_primary_10_1016_j_ophtha_2017_03_055 crossref_primary_10_38124_ijisrt_25may406 crossref_primary_10_1371_journal_pone_0274735 crossref_primary_10_1080_13813455_2020_1722704 crossref_primary_10_1177_2333721420934245 crossref_primary_10_1097_ICU_0000000000000436 crossref_primary_10_1097_NSG_0000000000000079 crossref_primary_10_1116_6_0003347 crossref_primary_10_1038_s41598_023_46253_2 crossref_primary_10_3760_cma_j_issn_0366_6999_20140241 crossref_primary_10_3389_fmed_2023_1036087 crossref_primary_10_1038_s41433_023_02615_8 crossref_primary_10_1371_journal_pone_0261897 crossref_primary_10_3390_life11070635 crossref_primary_10_1007_s11277_020_07186_5 crossref_primary_10_1016_j_chemolab_2023_104820 crossref_primary_10_3390_ijms25063230 crossref_primary_10_1111_aos_13706 crossref_primary_10_1007_s12020_021_02871_2 crossref_primary_10_1016_j_jddst_2025_107172 crossref_primary_10_1016_j_vhri_2018_11_002 crossref_primary_10_1080_09286586_2017_1290258 crossref_primary_10_1016_j_exer_2023_109610 crossref_primary_10_1038_eye_2015_3 crossref_primary_10_1186_s12886_022_02450_7 crossref_primary_10_1371_journal_pone_0142199 crossref_primary_10_1016_j_ophtha_2018_10_029 crossref_primary_10_1136_bjophthalmol_2021_319621 crossref_primary_10_1177_1120672120927256 crossref_primary_10_1371_journal_pone_0218613 crossref_primary_10_1186_s40662_020_00185_4 crossref_primary_10_2471_BLT_19_248708 crossref_primary_10_1016_j_transproceed_2015_07_034 crossref_primary_10_1007_s10456_024_09917_9 crossref_primary_10_1080_17469899_2021_1951232 crossref_primary_10_1016_j_ctcp_2019_101067 crossref_primary_10_1016_j_ajo_2022_01_026 crossref_primary_10_3390_diagnostics14212460 crossref_primary_10_1016_j_imu_2023_101285 crossref_primary_10_1038_s41598_023_35696_2 crossref_primary_10_1139_cjpp_2021_0036 crossref_primary_10_3390_nu14051086 crossref_primary_10_1038_s41598_024_71286_6 crossref_primary_10_1177_03000605221117134 crossref_primary_10_1016_S2213_8587_16_30081_X crossref_primary_10_1111_ceo_13330 crossref_primary_10_1155_2021_9524143 crossref_primary_10_12688_f1000research_170570_1 crossref_primary_10_1080_09286586_2016_1250918 crossref_primary_10_1097_IJG_0000000000002070 crossref_primary_10_1111_opo_13491 crossref_primary_10_4103_ijo_IJO_255_20 crossref_primary_10_1186_s12889_025_23680_6 crossref_primary_10_1136_bmjopen_2023_076116 crossref_primary_10_1177_2380084420954354 crossref_primary_10_4254_wjh_v16_i8_1156 crossref_primary_10_1007_s11357_020_00252_7 crossref_primary_10_3945_an_116_013177 |
| Cites_doi | 10.1016/S0140-6736(12)61689-4 10.5694/j.1326-5377.2005.tb06815.x 10.1001/archopht.122.4.477 10.1016/S0140-6736(13)61364-1 10.1001/archopht.116.5.653 10.1111/j.1755-3768.2010.02073.x 10.1186/1471-2415-9-8 10.1136/bjo.86.2.238 10.1016/j.ophtha.2006.01.035 10.1007/s00417-005-0206-1 10.3109/09286586.2012.741279 10.3109/09286586.2011.588908 10.1136/bjophthalmol-2011-300539 10.1016/S0140-6736(12)61729-2 10.1056/NEJM199111143252004 |
| ContentType | Journal Article |
| Contributor | Ellwein, Leon Resnikoff, Serge Dreer, Laura Tsilimbaris, Miltiadis Pesudovs, Konrad Kuhn, Ferenc Maguire, Maureen Joslin, Charlotte Pena, Fernando Yaa Virgili, Gianni Rossetti, Luca Dandona, Rakhi Hiratsuka, Yoshimune Stambolian, Dwght Cai, Feng Leasher, Janet Shetty, Rajesh Van Lansingh Keeffe, Jill Volmink, Jimmy Limburg, Hans Dekaris, Iva Budenz, Donald Brown, Derek Chakravarthy, Usha Bozkurt, Banu Gonzalez, Victor Sitorus, Rita S van Meurs, Jan Tejedor, Jaime Wormald, Richard Arditi, Aries Kuper, Hannah Frazier, Marcela Serle, Janet Frick, Kevin Robin, Alan Kymes, Steven Jonas, Jost Huang, John Wiedemann, Peter Kim, Judy Dandona, Lalit Lanzetta, Paolo Shen, Tueng Bennett, Michael Gichuhi, Stephen Hammond, Billy Hirai, Flavio Raju, Murugesan Hejtmancik, James Choi, Jaewan Dana, Reza Barkana, Yaniv Friedman, David Gao, Hua Naidoo, Kovin Morse, Alan Del Monte, Monte Braithwaite, Tasanee Gazzard, Andrew Palaiou, Maria Tielsch, James Wong, Tien Musch, David Bourne, Rupert Khairallah, Moncef Parodi, Maurizio Taylor, Hugh Sieving, Pamela Lambrou, George Javi |
| Contributor_xml | – sequence: 1 givenname: Rupert surname: Bourne fullname: Bourne, Rupert – sequence: 2 givenname: James surname: Tielsch fullname: Tielsch, James – sequence: 3 givenname: Tien surname: Wong fullname: Wong, Tien – sequence: 4 givenname: Derek surname: Brown fullname: Brown, Derek – sequence: 5 givenname: Usha surname: Chakravarthy fullname: Chakravarthy, Usha – sequence: 6 givenname: Leon surname: Ellwein fullname: Ellwein, Leon – sequence: 7 givenname: Jost surname: Jonas fullname: Jonas, Jost – sequence: 8 givenname: Jill surname: Keeffe fullname: Keeffe, Jill – sequence: 9 givenname: Hannah surname: Kuper fullname: Kuper, Hannah – sequence: 10 givenname: Janet surname: Leasher fullname: Leasher, Janet – sequence: 11 givenname: Maureen surname: Maguire fullname: Maguire, Maureen – sequence: 12 givenname: David surname: Musch fullname: Musch, David – sequence: 13 givenname: Kovin surname: Naidoo fullname: Naidoo, Kovin – sequence: 14 givenname: Maurizio surname: Parodi fullname: Parodi, Maurizio – sequence: 15 givenname: Pamela surname: Sieving fullname: Sieving, Pamela – sequence: 16 givenname: Hugh surname: Taylor fullname: Taylor, Hugh – sequence: 17 givenname: Kevin surname: Frick fullname: Frick, Kevin – sequence: 18 givenname: Konrad surname: Pesudovs fullname: Pesudovs, Konrad – sequence: 19 givenname: David surname: Friedman fullname: Friedman, David – sequence: 20 givenname: Rakhi surname: Dandona fullname: Dandona, Rakhi – sequence: 21 givenname: Lalit surname: Dandona fullname: Dandona, Lalit – sequence: 22 givenname: Jimmy surname: Volmink fullname: Volmink, Jimmy – sequence: 23 givenname: Alan surname: Robin fullname: Robin, Alan – sequence: 24 givenname: Jonathan surname: Javitt fullname: Javitt, Jonathan – sequence: 25 givenname: Serge surname: Resnikoff fullname: Resnikoff, Serge – sequence: 26 givenname: Stephen surname: Gichuhi fullname: Gichuhi, Stephen – sequence: 27 givenname: Steven surname: Kymes fullname: Kymes, Steven – sequence: 28 givenname: Hans surname: Limburg fullname: Limburg, Hans – sequence: 29 givenname: Tasanee surname: Braithwaite fullname: Braithwaite, Tasanee – sequence: 30 givenname: Gianni surname: Virgili fullname: Virgili, Gianni – sequence: 31 givenname: Fernando Yaa surname: Pena fullname: Pena, Fernando Yaa – sequence: 32 givenname: Mya surname: Sandar fullname: Sandar, Mya – sequence: 33 givenname: Paolo surname: Lanzetta fullname: Lanzetta, Paolo – sequence: 34 givenname: Judy surname: Kim fullname: Kim, Judy – sequence: 35 givenname: George surname: Lambrou fullname: Lambrou, George – sequence: 36 givenname: Dwght surname: Stambolian fullname: Stambolian, Dwght – sequence: 37 givenname: Peter surname: Wiedemann fullname: Wiedemann, Peter – sequence: 38 givenname: Aries surname: Arditi fullname: Arditi, Aries – sequence: 39 givenname: Yaniv surname: Barkana fullname: Barkana, Yaniv – sequence: 40 givenname: Banu surname: Bozkurt fullname: Bozkurt, Banu – sequence: 41 givenname: Donald surname: Budenz fullname: Budenz, Donald – sequence: 42 givenname: Feng surname: Cai fullname: Cai, Feng – sequence: 43 givenname: Jaewan surname: Choi fullname: Choi, Jaewan – sequence: 44 givenname: Iva surname: Dekaris fullname: Dekaris, Iva – sequence: 45 givenname: Jenny surname: Deva fullname: Deva, Jenny – sequence: 46 givenname: Laura surname: Dreer fullname: Dreer, Laura – sequence: 47 givenname: Marcela surname: Frazier fullname: Frazier, Marcela – sequence: 48 givenname: Andrew surname: Gazzard fullname: Gazzard, Andrew – sequence: 49 givenname: Billy surname: Hammond fullname: Hammond, Billy – sequence: 50 givenname: Mary Elizabeth surname: Hartnett fullname: Hartnett, Mary Elizabeth – sequence: 51 givenname: Flavio surname: Hirai fullname: Hirai, Flavio – sequence: 52 givenname: John surname: Huang fullname: Huang, John – sequence: 53 givenname: Charlotte surname: Joslin fullname: Joslin, Charlotte – sequence: 54 givenname: Jennifer surname: Lim fullname: Lim, Jennifer – sequence: 55 givenname: Alan surname: Morse fullname: Morse, Alan – sequence: 56 givenname: Murugesan surname: Raju fullname: Raju, Murugesan – sequence: 57 givenname: Luca surname: Rossetti fullname: Rossetti, Luca – sequence: 58 givenname: Janet surname: Serle fullname: Serle, Janet – sequence: 59 givenname: Tueng surname: Shen fullname: Shen, Tueng – sequence: 60 givenname: Rajesh surname: Shetty fullname: Shetty, Rajesh – sequence: 61 givenname: Jaime surname: Tejedor fullname: Tejedor, Jaime – sequence: 62 givenname: Miltiadis surname: Tsilimbaris fullname: Tsilimbaris, Miltiadis – sequence: 63 givenname: Jan surname: van Meurs fullname: van Meurs, Jan – sequence: 64 givenname: Maria surname: Palaiou fullname: Palaiou, Maria – sequence: 65 givenname: Monte surname: Del Monte fullname: Del Monte, Monte – sequence: 66 givenname: April surname: Ingram fullname: Ingram, April – sequence: 67 givenname: Hua surname: Gao fullname: Gao, Hua – sequence: 68 givenname: Moncef surname: Khairallah fullname: Khairallah, Moncef – sequence: 69 givenname: James surname: Hejtmancik fullname: Hejtmancik, James – sequence: 70 givenname: Reza surname: Dana fullname: Dana, Reza – sequence: 71 givenname: Victor surname: Gonzalez fullname: Gonzalez, Victor – sequence: 72 givenname: Michael surname: Bennett fullname: Bennett, Michael – sequence: 73 givenname: Yoshimune surname: Hiratsuka fullname: Hiratsuka, Yoshimune – sequence: 74 givenname: Ferenc surname: Kuhn fullname: Kuhn, Ferenc – sequence: 75 surname: Van Lansingh fullname: Van Lansingh – sequence: 76 givenname: Rita S surname: Sitorus fullname: Sitorus, Rita S – sequence: 77 givenname: Richard surname: Wormald fullname: Wormald, Richard |
| Copyright | 2013 Bourne et al. Open Access article distributed under the terms of CC BY Bourne et al. Open Access article distributed under the terms of CC BY Copyright © 2013 Bourne et al. Open Access article distributed under the terms of CC BY. Published by .. All rights reserved. |
| Copyright_xml | – notice: 2013 Bourne et al. Open Access article distributed under the terms of CC BY – notice: Bourne et al. Open Access article distributed under the terms of CC BY – notice: Copyright © 2013 Bourne et al. Open Access article distributed under the terms of CC BY. Published by .. All rights reserved. |
| CorporateAuthor | on behalf of the Vision Loss Expert Group Vision Loss Expert Group |
| CorporateAuthor_xml | – name: on behalf of the Vision Loss Expert Group – name: Vision Loss Expert Group |
| DBID | 6I. AAFTH AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 DOA |
| DOI | 10.1016/S2214-109X(13)70113-X |
| DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Public Health |
| EISSN | 2214-109X |
| EndPage | e349 |
| ExternalDocumentID | oai_doaj_org_article_54bc55e85c2642c5af5158724319a6c3 25104599 10_1016_S2214_109X_13_70113_X S2214109X1370113X 1_s2_0_S2214109X1370113X |
| Genre | Meta-Analysis Review Research Support, Non-U.S. Gov't Journal Article |
| GrantInformation | Bill & Melinda Gates Foundation, Fight for Sight, Fred Hollows Foundation, and Brien Holden Vision Institute. |
| GroupedDBID | .1- .FO 0R~ 1P~ 457 53G AAEDT AAEDW AAIKJ AALRI AAMRU AAXUO AAYWO ABMAC ACGFS ACHQT ACVFH ADBBV ADCNI ADEZE ADVLN AENEX AEUPX AEVXI AEXQZ AFPUW AFRHN AFTJW AGHFR AIGII AITUG AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ APXCP BAWUL BCNDV DIK EBS EJD FDB GROUPED_DOAJ HZ~ IPNFZ IXB KQ8 M41 M~E O9- OD. OK1 OO~ RIG ROL SSZ Z5R 0SF 6I. AACTN AAFTH NCXOZ AFCTW AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
| ID | FETCH-LOGICAL-c653t-8d51f3c35320e0e3588fd195b7bf67cc41cadb155a43da266e481137dda4f983 |
| IEDL.DBID | DOA |
| ISICitedReferencesCount | 1310 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000336423600017&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 2214-109X |
| IngestDate | Fri Oct 03 12:50:29 EDT 2025 Wed Oct 01 13:29:50 EDT 2025 Mon Jul 21 06:03:45 EDT 2025 Tue Nov 18 22:26:56 EST 2025 Sat Nov 29 01:56:29 EST 2025 Wed May 17 02:14:19 EDT 2023 Sun Feb 23 10:19:25 EST 2025 Tue Aug 26 16:32:27 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 6 |
| Language | English |
| License | http://creativecommons.org/licenses/by-nc-nd/4.0 Copyright © 2013 Bourne et al. Open Access article distributed under the terms of CC BY. Published by .. All rights reserved. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c653t-8d51f3c35320e0e3588fd195b7bf67cc41cadb155a43da266e481137dda4f983 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 |
| OpenAccessLink | https://doaj.org/article/54bc55e85c2642c5af5158724319a6c3 |
| PMID | 25104599 |
| PQID | 1552375409 |
| PQPubID | 23479 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_54bc55e85c2642c5af5158724319a6c3 proquest_miscellaneous_1552375409 pubmed_primary_25104599 crossref_primary_10_1016_S2214_109X_13_70113_X crossref_citationtrail_10_1016_S2214_109X_13_70113_X elsevier_sciencedirect_doi_10_1016_S2214_109X_13_70113_X elsevier_clinicalkeyesjournals_1_s2_0_S2214109X1370113X elsevier_clinicalkey_doi_10_1016_S2214_109X_13_70113_X |
| PublicationCentury | 2000 |
| PublicationDate | 2013-12-01 |
| PublicationDateYYYYMMDD | 2013-12-01 |
| PublicationDate_xml | – month: 12 year: 2013 text: 2013-12-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England |
| PublicationTitle | The Lancet global health |
| PublicationTitleAlternate | Lancet Glob Health |
| PublicationYear | 2013 |
| Publisher | Elsevier Ltd Elsevier |
| Publisher_xml | – name: Elsevier Ltd – name: Elsevier |
| References | Murray, Vos, Lozano (bib9) 2013; 380 Kempen (bib26) 2011; 18 Peterson, Flaxman (bib14) 2013; 381 Foster, Buhrmann, Quigley (bib23) 2002; 86 Resnikoff, Pascolini, Etya'ale (bib7) 2004; 82 Schellini, Durkin, Hoyama (bib19) 2009; 9 Myerson, Rosenfeld, Lim, Murray (bib15) 2011 Thylefors, Négrel, Pararajasegaram, Dadzie (bib5) 1995; 73 Bourne, Price, Taylor (bib11) 2013; 20 (bib6) 2000 Xu, Li, Cui, Jonas (bib21) 2006; 244 bib25 Xu, Wang, Li (bib18) 2006; 113 Sommer, Tielsch, Katz (bib1) 1991; 325 Klaver, Wolfs, Vingerling, Hofman, de Jong (bib3) 1998; 116 Pascolini, Mariotti (bib8) 2012; 96 Smith, Mann, Haddad (bib13) Nangia, Jonas, Sinha, Gupta, Bhojwani (bib22) 2012; 90 Chang, Cañizares, Cuenca (bib20) 2009 Stevens, White, Flaxman (bib12) 2013 bib16 Wolfs, Borger, Ramrattan (bib24) 2000; 41 Taylor, Keeffe, Vu (bib2) 2005; 182 Congdon, O'Colmain, Klaver (bib4) 2004; 122 Ahmad, Boschi-Pinto, Lopez (bib17) 2001 Vos, Flaxman, Naghavi (bib10) 2013; 380 Vos (10.1016/S2214-109X(13)70113-X_bib10) 2013; 380 Xu (10.1016/S2214-109X(13)70113-X_bib21) 2006; 244 Nangia (10.1016/S2214-109X(13)70113-X_bib22) 2012; 90 Foster (10.1016/S2214-109X(13)70113-X_bib23) 2002; 86 Klaver (10.1016/S2214-109X(13)70113-X_bib3) 1998; 116 Thylefors (10.1016/S2214-109X(13)70113-X_bib5) 1995; 73 Murray (10.1016/S2214-109X(13)70113-X_bib9) 2013; 380 Peterson (10.1016/S2214-109X(13)70113-X_bib14) 2013; 381 Myerson (10.1016/S2214-109X(13)70113-X_bib15) 2011 Taylor (10.1016/S2214-109X(13)70113-X_bib2) 2005; 182 Sommer (10.1016/S2214-109X(13)70113-X_bib1) 1991; 325 Pascolini (10.1016/S2214-109X(13)70113-X_bib8) 2012; 96 (10.1016/S2214-109X(13)70113-X_bib6) 2000 Ahmad (10.1016/S2214-109X(13)70113-X_bib17) 2001 Wolfs (10.1016/S2214-109X(13)70113-X_bib24) 2000; 41 Schellini (10.1016/S2214-109X(13)70113-X_bib19) 2009; 9 Kempen (10.1016/S2214-109X(13)70113-X_bib26) 2011; 18 Stevens (10.1016/S2214-109X(13)70113-X_bib12) 2013 Smith (10.1016/S2214-109X(13)70113-X_bib13) Bourne (10.1016/S2214-109X(13)70113-X_bib11) 2013; 20 Congdon (10.1016/S2214-109X(13)70113-X_bib4) 2004; 122 Resnikoff (10.1016/S2214-109X(13)70113-X_bib7) 2004; 82 Chang (10.1016/S2214-109X(13)70113-X_bib20) 2009 Xu (10.1016/S2214-109X(13)70113-X_bib18) 2006; 113 25104584 - Lancet Glob Health. 2013 Dec;1(6):e311-2 25104662 - Lancet Glob Health. 2014 Feb;2(2):e76-7 |
| References_xml | – volume: 82 start-page: 844 year: 2004 end-page: 851 ident: bib7 article-title: Global data on visual impairment in the year 2002 publication-title: Bull World Health Organ – volume: 96 start-page: 614 year: 2012 end-page: 618 ident: bib8 article-title: Global estimates of visual impairment: 2010 publication-title: Br J Ophthalmol – volume: 325 start-page: 1412 year: 1991 end-page: 1417 ident: bib1 article-title: Racial differences in the cause-specific prevalence of blindness in east Baltimore publication-title: N Engl J Med – year: 2013 ident: bib12 article-title: Global prevalence of visual impairment and blindness: magnitude and temporal trends, 1990–2010 publication-title: Ophthalmology – ident: bib16 article-title: Trachoma: status of endemicity for blinding trachoma by country – volume: 244 start-page: 871 year: 2006 end-page: 873 ident: bib21 article-title: Frequency of under-corrected refractive error in elderly Chinese in Beijing publication-title: Graefes Arch Clin Exp Ophthalmol – volume: 116 start-page: 653 year: 1998 end-page: 658 ident: bib3 article-title: Age-specific prevalence and causes of blindness and visual impairment in an older population: the Rotterdam Study publication-title: Arch Ophthalmol – volume: 182 start-page: 565 year: 2005 end-page: 568 ident: bib2 article-title: Vision loss in Australia publication-title: Med J Aust – volume: 18 start-page: 99 year: 2011 end-page: 102 ident: bib26 article-title: The need for a revised approach to epidemiological monitoring of the prevalence of visual impairment publication-title: Ophthalmic Epidemiol – volume: 380 start-page: 2197 year: 2013 end-page: 2223 ident: bib9 article-title: Disability-adjusted life-years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 publication-title: Lancet – volume: 122 start-page: 477 year: 2004 end-page: 485 ident: bib4 article-title: Causes and prevalence of visual impairment among adults in the United States publication-title: Arch Ophthalmol – volume: 73 start-page: 115 year: 1995 end-page: 121 ident: bib5 article-title: Global data on blindness publication-title: Bull World Health Organ – year: 2001 ident: bib17 publication-title: Age standardization of rates: a new WHO standard – year: 2009 ident: bib20 publication-title: Investigación rápida de la ceguera evitable. Estudio RAAB—Ecuador – volume: 380 start-page: 2163 year: 2013 end-page: 2196 ident: bib10 article-title: Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 publication-title: Lancet – volume: 41 start-page: 3309 year: 2000 end-page: 3321 ident: bib24 article-title: Changing views on open-angle glaucoma: definitions and prevalences—The Rotterdam Study publication-title: Invest Ophthalmol Vis Sci – volume: 86 start-page: 238 year: 2002 end-page: 242 ident: bib23 article-title: The definition and classification of glaucoma in prevalence surveys publication-title: Br J Ophthalmol – volume: 90 start-page: E166 year: 2012 end-page: E167 ident: bib22 article-title: Prevalence of undercorrection of refractive error in rural Central India. The Central India Eye and Medical Study publication-title: Acta Ophthalmol – volume: 113 start-page: 1141.e1 year: 2006 ident: bib18 article-title: Causes of blindness and visual impairment in an urban and rural area in Beijing: the Beijing Eye Study publication-title: Ophthalmology – start-page: 85 year: 2011 ident: bib15 article-title: Safe pregnancy and delivery: a systematic analysis of the trends in the coverage of antenatal and intrapartum care publication-title: Global health metrics and evaluation: controversies, innovation, accountability – ident: bib25 article-title: Coding instructions for the WHO/PBL eye examination record (version III) – year: 2000 ident: bib6 publication-title: Global initiative for the elimination of avoidable blindness (WHO/PBL/97.61 Rev 2) – volume: 9 start-page: 8 year: 2009 ident: bib19 article-title: Prevalence and causes of visual impairment in a Brazilian population: the Botucatu Eye Study publication-title: BMC Ophthalmol – volume: 20 start-page: 33 year: 2013 end-page: 39 ident: bib11 article-title: New systematic review methodology for visual impairment and blindness for the 2010 Global Burden of Disease study publication-title: Ophthalmic Epidemiol – volume: 381 start-page: S110 year: 2013 ident: bib14 article-title: Meta-regression with DisMod-MR: how robust is the model? publication-title: Lancet – ident: bib13 article-title: Global Atlas of Trachoma – volume: 82 start-page: 844 year: 2004 ident: 10.1016/S2214-109X(13)70113-X_bib7 article-title: Global data on visual impairment in the year 2002 publication-title: Bull World Health Organ – volume: 380 start-page: 2197 year: 2013 ident: 10.1016/S2214-109X(13)70113-X_bib9 article-title: Disability-adjusted life-years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 publication-title: Lancet doi: 10.1016/S0140-6736(12)61689-4 – volume: 182 start-page: 565 year: 2005 ident: 10.1016/S2214-109X(13)70113-X_bib2 article-title: Vision loss in Australia publication-title: Med J Aust doi: 10.5694/j.1326-5377.2005.tb06815.x – volume: 122 start-page: 477 year: 2004 ident: 10.1016/S2214-109X(13)70113-X_bib4 article-title: Causes and prevalence of visual impairment among adults in the United States publication-title: Arch Ophthalmol doi: 10.1001/archopht.122.4.477 – volume: 381 start-page: S110 year: 2013 ident: 10.1016/S2214-109X(13)70113-X_bib14 article-title: Meta-regression with DisMod-MR: how robust is the model? publication-title: Lancet doi: 10.1016/S0140-6736(13)61364-1 – year: 2009 ident: 10.1016/S2214-109X(13)70113-X_bib20 – volume: 116 start-page: 653 year: 1998 ident: 10.1016/S2214-109X(13)70113-X_bib3 article-title: Age-specific prevalence and causes of blindness and visual impairment in an older population: the Rotterdam Study publication-title: Arch Ophthalmol doi: 10.1001/archopht.116.5.653 – start-page: 85 year: 2011 ident: 10.1016/S2214-109X(13)70113-X_bib15 article-title: Safe pregnancy and delivery: a systematic analysis of the trends in the coverage of antenatal and intrapartum care – volume: 90 start-page: E166 year: 2012 ident: 10.1016/S2214-109X(13)70113-X_bib22 article-title: Prevalence of undercorrection of refractive error in rural Central India. The Central India Eye and Medical Study publication-title: Acta Ophthalmol doi: 10.1111/j.1755-3768.2010.02073.x – volume: 9 start-page: 8 year: 2009 ident: 10.1016/S2214-109X(13)70113-X_bib19 article-title: Prevalence and causes of visual impairment in a Brazilian population: the Botucatu Eye Study publication-title: BMC Ophthalmol doi: 10.1186/1471-2415-9-8 – volume: 86 start-page: 238 year: 2002 ident: 10.1016/S2214-109X(13)70113-X_bib23 article-title: The definition and classification of glaucoma in prevalence surveys publication-title: Br J Ophthalmol doi: 10.1136/bjo.86.2.238 – year: 2013 ident: 10.1016/S2214-109X(13)70113-X_bib12 article-title: Global prevalence of visual impairment and blindness: magnitude and temporal trends, 1990–2010 publication-title: Ophthalmology – volume: 113 start-page: 1141.e1 year: 2006 ident: 10.1016/S2214-109X(13)70113-X_bib18 article-title: Causes of blindness and visual impairment in an urban and rural area in Beijing: the Beijing Eye Study publication-title: Ophthalmology doi: 10.1016/j.ophtha.2006.01.035 – volume: 244 start-page: 871 year: 2006 ident: 10.1016/S2214-109X(13)70113-X_bib21 article-title: Frequency of under-corrected refractive error in elderly Chinese in Beijing publication-title: Graefes Arch Clin Exp Ophthalmol doi: 10.1007/s00417-005-0206-1 – volume: 20 start-page: 33 year: 2013 ident: 10.1016/S2214-109X(13)70113-X_bib11 article-title: New systematic review methodology for visual impairment and blindness for the 2010 Global Burden of Disease study publication-title: Ophthalmic Epidemiol doi: 10.3109/09286586.2012.741279 – volume: 18 start-page: 99 year: 2011 ident: 10.1016/S2214-109X(13)70113-X_bib26 article-title: The need for a revised approach to epidemiological monitoring of the prevalence of visual impairment publication-title: Ophthalmic Epidemiol doi: 10.3109/09286586.2011.588908 – volume: 96 start-page: 614 year: 2012 ident: 10.1016/S2214-109X(13)70113-X_bib8 article-title: Global estimates of visual impairment: 2010 publication-title: Br J Ophthalmol doi: 10.1136/bjophthalmol-2011-300539 – ident: 10.1016/S2214-109X(13)70113-X_bib13 – volume: 41 start-page: 3309 year: 2000 ident: 10.1016/S2214-109X(13)70113-X_bib24 article-title: Changing views on open-angle glaucoma: definitions and prevalences—The Rotterdam Study publication-title: Invest Ophthalmol Vis Sci – volume: 73 start-page: 115 year: 1995 ident: 10.1016/S2214-109X(13)70113-X_bib5 article-title: Global data on blindness publication-title: Bull World Health Organ – volume: 380 start-page: 2163 year: 2013 ident: 10.1016/S2214-109X(13)70113-X_bib10 article-title: Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 publication-title: Lancet doi: 10.1016/S0140-6736(12)61729-2 – year: 2000 ident: 10.1016/S2214-109X(13)70113-X_bib6 – volume: 325 start-page: 1412 year: 1991 ident: 10.1016/S2214-109X(13)70113-X_bib1 article-title: Racial differences in the cause-specific prevalence of blindness in east Baltimore publication-title: N Engl J Med doi: 10.1056/NEJM199111143252004 – year: 2001 ident: 10.1016/S2214-109X(13)70113-X_bib17 – reference: 25104584 - Lancet Glob Health. 2013 Dec;1(6):e311-2 – reference: 25104662 - Lancet Glob Health. 2014 Feb;2(2):e76-7 |
| SSID | ssj0000993277 |
| Score | 2.5695531 |
| SecondaryResourceType | review_article |
| Snippet | Data on causes of vision impairment and blindness are important for development of public health policies, but comprehensive analysis of change in prevalence... Summary Background Data on causes of vision impairment and blindness are important for development of public health policies, but comprehensive analysis of... Background: Data on causes of vision impairment and blindness are important for development of public health policies, but comprehensive analysis of change in... |
| SourceID | doaj proquest pubmed crossref elsevier |
| SourceType | Open Website Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | e339 |
| SubjectTerms | Blindness - etiology Cataract - complications Diabetic Retinopathy - complications Female Glaucoma - complications Global Health Humans Internal Medicine Macular Degeneration - complications Male Trachoma - complications Vision Disorders - etiology |
| Title | Causes of vision loss worldwide, 1990–2010: a systematic analysis |
| URI | https://www.clinicalkey.com/#!/content/1-s2.0-S2214109X1370113X https://www.clinicalkey.es/playcontent/1-s2.0-S2214109X1370113X https://dx.doi.org/10.1016/S2214-109X(13)70113-X https://www.ncbi.nlm.nih.gov/pubmed/25104599 https://www.proquest.com/docview/1552375409 https://doaj.org/article/54bc55e85c2642c5af5158724319a6c3 |
| Volume | 1 |
| WOSCitedRecordID | wos000336423600017&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 2214-109X dateEnd: 20231231 omitProxy: false ssIdentifier: ssj0000993277 issn: 2214-109X databaseCode: DOA dateStart: 20130101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 2214-109X dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000993277 issn: 2214-109X databaseCode: M~E dateStart: 20130101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3LbtQwFLWgYoGEUKE8pi2VkboAidDxK7a7K6NWbKgqtYvsLMcPaVA1g5oZ2KH-A3_Il_TazqStBBoWbLKIcuPk5jrnJLbPQWg_OC9UHVVVc0IrHpIbYBt4JTTAS6gVVJnLZhPy9FQ1jT67Y_WV5oQVeeCSuAPBWydEUMIBdFMnbAQEVpIC8Glbu6zzCaznzsfU18J7GM22i5QSDu8a3dwu3zk4H3a-I-y9hBJnVXMPmLJ-_z18-hv_zDh0some9gQSH5ULf4YehNlz9KT8fcNlUdEWmkzssgsdnkdcFo_jS2gTZ3nUH1MfPmAC-PD7-lcapT7EFt8KOmPby5S8QBcnxxeTz1Vvl1C5WrBFpbwgkTmWrB7CODChVPREi1a2sZbOceKsb4E_WM68BWAOXMGdS-8tj1qxl2hjNp-F1wgzz4kCqtNaHjiRY20jfLk4GZhkkWg1QnyVKuN6KfHkaHFphjljKcNpdLsxhJmcYdOM0Mch7FvR0lgX8Ck9h-HgJIWdd0CBmL5AzLoCGaF69RTNarUpvB_hRNN1rcs_BYau7-WdIaajZlyiUzAkM4VCpBoieyJTCMq_NPp2VWgGOnoavbGzMF9CY0LQ5Fc81iP0qlTgkBggqUDNtd7-HwnbQY9p8vzIc3Z20cbiahneoEfu-2LaXe2hh7JRe7m3wfbLz-Mba0wiBg |
| linkProvider | Directory of Open Access Journals |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Causes+of+vision+loss+worldwide%2C+1990-2010%3A+a+systematic+analysis&rft.jtitle=The+Lancet+global+health&rft.au=Bourne%2C+Rupert+R+A&rft.au=Stevens%2C+Gretchen+A&rft.au=White%2C+Richard+A&rft.au=Smith%2C+Jennifer+L&rft.date=2013-12-01&rft.issn=2214-109X&rft.eissn=2214-109X&rft.volume=1&rft.issue=6&rft.spage=e339&rft_id=info:doi/10.1016%2FS2214-109X%2813%2970113-X&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_m | http://cvtisr.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F2214109X%2FS2214109X13X70093%2Fcov150h.gif |